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Sudden unexplained death occurs in multiple populations. Significant evidence suggests 
fatality was due to cardiorespiratory failure—likely in response to an exogenous stressor 
which created an immediate hypercapnic (increased carbon dioxide) or hypoxic 
(decreased oxygen) environment. Research into the mechanism(s) of failure has focused 
on the brainstem (the classic cardiorespiratory control center) to no avail. Recently, 
research has probed outside of the brainstem to identify structures that may play a 
specific modulatory role during stressful conditions such as hypoxia and hypercapnia, for 
example the cerebellum, which houses a pair of chemosensitive nuclei, the fastigial 
nuclei (FN). As the Purkinje cells of the cerebellar vermis primarily innervate the FN, 
and global cerebellar Purkinje cell loss inhibits the ability to respond to and recover from 
mild hypoxic and hypercapnic stressors, the purpose of this study was to examine the 
respiratory responses of multiple animal models of developmental cerebellar Purkinje cell 
loss or dysfunction to hypoxic and hypercapnic stressors. It was hypothesized that 
cerebellar Purkinje cell loss or dysfunction, regardless of extent, would result in a 
reduced ability to respond to and recover from hypoxic and hypercapnic stressors. 
Twelve male sibling mutant and wildtype mouse pairs from three strains (Fmr1, Lurcher, 
and mdx) on three different genetic backgrounds (FVB, B6, and B10 respectively) were 
exposed to multiple environmental stressors with periods of recovery in normal room air 
in a whole body plethysmography system. Respiratory minute ventilation (MV) patterns 
	
vi 
were examined for changes in depth of breathing, breath frequency, and pausing between 
breaths. Results of multiple mixed analyses of covariance indicated all animals responded 
accordingly to the hypoxic and hypercapnic stressors by increasing their MV and 
subsequently decreasing MV when allowed to recover in normal conditions. However, 
regardless of strain, all mutant animals with cerebellar Purkinje cell loss or dysfunction 
were slower to respond to stressors and revealed patterns of disordered breathing during 
recovery. As cerebellar Purkinje cell loss or dysfunction and disordered breathing are 
common in multiple populations at risk for sudden unexplained death, the precise role of 
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Chapter 1: Introduction 
Sudden Unexplained Death 
 Sudden unexplained death occurs in multiple populations including infants 
(sudden infant death syndrome; SIDS), persons with epilepsy (sudden unexplained death 
in epilepsy; SUDEP), children (sudden unexpected death in childhood; SUDC), and 
adults (sudden unexpected death syndrome; SUDS) among others, and is a pervasive 
problem that demands solving. In each of these cases, the victims appeared otherwise 
healthy prior to the fatal event, are typically males, and are found in bed in the prone 
position suggesting the distinct possibility that the fatal event has occurred during sleep 
(Krous et al., 2004; Moon, Horne, & Hauck, 2007; NICHD, 2001). Diagnosis for each of 
these disorders is exclusionary—no known cause of death is found even following a full 
investigation and autopsy. Although the precise cause of death is not known across these 
populations, there are often factors surrounding the deaths that have led many 
investigators to conclude that cardiorespiratory failure occurred, culminating in the fatal 
event. In addition to inherited vulnerabilities there are often interesting and unifying 
neuropathological findings during histological examination of the brains of these victims 
that suggest that there may be some commonality in the neural mechanisms contributing 
to the vulnerability to these disorders.  
 Sudden infant death syndrome. SIDS is defined as the sudden, unexpected death of 
an infant less than 1 year of age (Krous et al., 2004). SIDS risk vulnerability begins 
shortly after birth, with few deaths occurring before one month of age, and peaks between 
two and four months of age (Task Force on Sudden Infant Death Syndrome, 2005). The 
principal explanation for the cause of SIDS, the triple-risk hypothesis, is multifactorial 
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and states that in order to be identified as a SIDS victim three factors must converge: an 
infant must have been at a critical period of development, have an unknown brain 
abnormality, and been exposed to an exogenous stressor (Filiano & Kinney, 1994; 
NICHD, 2001). Of the three factors involved in the triple-risk SIDS hypothesis, 
exogenous stressors are unique in that researchers have been able to specifically identify 
and educate the public about many of these stressors and subsequently reduce overall 
SIDS deaths (Task Force on Sudden Infant Death Syndrome, 2005; Trachtenberg, Haas, 
Kinney, Stanley, & Krous, 2012). Because the majority of SIDS deaths are thought to 
occur during sleep, investigation of exogenous stressors is typically focused on stressful 
sleeping conditions such as prone sleeping, or sleeping in soft bedding. These stressors 
are known to either increase the infant’s immediate environmental levels of carbon 
dioxide (CO2), or decrease available oxygen (O2), or both. Although the identification of 
these exogenous stressors has, over two decades, reduced SIDS deaths, this condition 
remains the leading cause of unexplained death in infants, which affirms the importance 
of investigating and understanding the factors involved in SIDS vulnerability (Hauck & 
Tanabe, 2008; Moon et al., 2007; NICHD, 2001; Trachtenberg et al., 2012).  
 Considerable evidence has suggested that SIDS occurs due to cardiorespiratory 
failure. This is a reasonable conclusion as the stressors an infant may be exposed to cause 
changes in the infant’s environmental levels of CO2 and O2 that challenge homeostatic 
cardiac and respiratory mechanisms (e.g., sleeping in soft bedding, in the prone position, 
etc…). Accordingly, research has focused on the cardiac and pulmonary musculature and 
related brain systems involved in maintaining and regulating cardiorespiratory function. 
Specific attention has been paid to pontine and medullary regions of the hindbrain as they 
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have been established as control centers of normal, rhythmic respiratory and cardiac 
output (Bianchi, Denavit-Saubie, & Champagnat, 1995). However, when these systems 
are challenged (e.g.,, an increase in environmental CO2), additional central nervous 
system (CNS) structures may be recruited to initiate and maintain appropriate 
compensatory responses including increased respiration, increased heart rate, 
repositioning, or even arousal. Thus, only recently has SIDS research extended into 
investigation of neural systems outside of the brainstem into brain areas including the 
cerebellum, which may modulate cardiorespiratory behavior under challenging or 
stressful conditions (Harper, 2000).  
 The influence of the cerebellum in SIDS remains controversial with mixed 
support for the hypothesis that this brain area plays a causal role in fatal events. For 
example, while Cruz-Sanchez et al. (1997) found evidence of delayed cerebellar cortex 
maturation in SIDS victims compared to controls, two additional reports found no 
difference in cerebellar pathology between SIDS victims and controls (Kiessling et al., 
2013; Oehmichen, Wullen, Zilles, & Saternus, 1989). It is important to note in the two 
non-supporting studies that the hypoxic conditions (e.g.,, pneumonia, asphyxia, 
suffocation, carbon monoxide poisoning) that preceded many of the control deaths may 
have contributed to the inability to find these differences as it has been shown repeatedly 
that the infant cerebellum is especially vulnerable to hypoxic insult resulting in neuronal 
death (Campanille et al., 2015, Huang & Castillo, 2008; Sarna & Hawkes, 2003). 
Additionally, because the infant cerebellum is especially vulnerable to hypoxic insult, 
these studies cannot differentiate the possibility that pre-existing cerebellar 
neuropathology led to the fatal event from the competing hypothesis that episodes of 
	
4 
recurrent non-fatal hypoxia ultimately led to the fatal event, but also resulted in hypoxic 
cerebellar damage. Because of likely variability in the many factors associated with 
autopsy procedures it is also possible that the observed cerebellar hypoxic damage is tied 
to variables related to the time interval between the fatal event and discovery, or possibly 
the duration of the fatal event.  
 Sudden unexplained death in epilepsy. SUDEP is defined as unexplained death in 
persons with epilepsy who (aside from seizures) appeared otherwise healthy before the 
fatal event (Nashef, 1997). Deaths that can be attributed to secondary events that unfold 
relative to ictal or postictal periods (e.g., hitting head, drowning, etc…) are not included 
in a SUDEP diagnosis. Similar to SIDS, research has reported elevated risk for SUDEP in 
males [with epilepsy], during sleep, with victims often found deceased in the early 
morning hours in bed, and in the prone position (Kloster & Engelskjøn, 1999; Tomson, 
Nashef, Hindocha, & Makoff, 2007). Additional risk factors for SUDEP include a history 
of multiple monthly seizures, especially grand-mal seizures, middle age (20 – 40 years), 
polytherapy with multiple antiepileptic drugs (AEDs), poor compliance with AEDs, 
alcohol abuse, and intellectual disabilities including autism spectrum disorders (ASD) 
which frequently present comorbidly with epilepsy (Hughes, 2009; Kiani et al., 2014; 
Kloster & Engelskjøn, 1999). Hypotheses for the causes of SUDEP again emphasize the 
likelihood of cardiorespiratory failure. Thus, investigation into the causes of SUDEP has 
also focused extensively on the brainstem. It should be noted, however, that 
neuropathological findings from SUDEP victims have suggested the necessity of 
examining areas outside the brainstem in an effort to find causal influences on the 
susceptibility for SUDEP.  
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 Cerebellar pathology including atrophy and Purkinje cell loss is common in both 
patients with chronic epilepsy and victims of SUDEP (Botez, Attig, & Vezina, 1988; 
Dam, 1987; Thom et al., 2015). Neuropathology of the cerebellum has often been 
attributed to the reoccurrence of grand-mal seizures resulting in hypoxic brain injury, and 
the use of antiepileptic drugs such as phenytoin has been shown to induce cerebellar cell 
death (Botez et al., 1988; Brostoff, Birns, & McCrea, 2008; Dam, 1987; Eldridge, Stern, 
Anainen, Koerber, & Wilder, 1983; Mclain, Martin, & Allen, 1980). However, even 
without AEDs, clinical research indicates that cerebellar pathology is much more 
common in patients with epilepsy and is related to seizure frequency (Bohnen, O’Brien, 
Mullan, & So, 1998). Preclinical research also confirms a significant relationship 
between seizures and neuronal loss in the cerebellum (Dam et al., 1984; Lomoio et al., 
2011). More specifically, increased severity and frequency of seizures results in 
decreased cerebellar Purkinje cell density (Lomoio, Necchi, Mares, & Scherini, 2011). 
Thus, cerebellar neuropathology can occur as a function of AED treatment or from the 
repeated hypoxic episodes that accompany seizures.  
 Sudden unexplained death in childhood. SUDC is the unexplained death of a child 
greater than 1 year of age extending up until 18 years of age (Hefti et al., 2016; Krous, 
Chadwick, Crandall, & Nadeau-Manning, 2005). Similar to SIDS, these deaths primarily 
occur in males during sleep and the victims are often found in the prone position, again 
raising the possibility these deaths could have arisen from acute cardiorespiratory failure. 
However, the phenomenon of SUDC has not been as extensively reported as SIDS and 
thus knowledge is limited. Recent research on 151 referred children victims in San Diego 
who perished from known causes, unknown causes, seizure-related causes, and SUDC 
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has provided little insight into identifying unifying features of SUDC, but did reveal the 
necessity of instituting a nationwide autopsy protocol to further the knowledge on SUDC 
(Hefti et al., 2016).  
 Sudden Unexpected Death Syndrome. Unlike SIDS, SUDEP, and the more recently 
described SUDC, SUDS has yet to be universally defined. The suggested windows of 
time that characterize this sudden death syndrome have been variably described as above 
the age of one year (Morentin, Suárez-Mier, & Aguilera, 2003), at least the age of two 
years (Tungsanga & Sriboonlue, 1993), between the ages of 20-39 (Gervacio-Domingo, 
Punzalan, Amarillo, & Dans, 2007), and young adult below the age of 40 (Elfawal, 
2000). Further there is inconsistent use of terminology to describe this syndrome from the 
addition of the term “nocturnal” to describe sudden unexpected nocturnal death 
syndrome, to interchanging of the terms unexpected and unexplained, the omission of 
both terms (unexpected and unexplained) altogether referring to it simply as sudden death 
syndrome, or even the reference to “dead in bed syndrome” which is most frequently 
used to describe sudden unexplained death in diabetes patients. Similar to SIDS, SUDEP, 
and SUDC, most victims of SUDS are males found in bed following periods of sleep, and 
complete autopsies and scene investigations yield no causal factors of the death (Elfawal, 
2000; Furst, 1982; Gervacio-Domingo et al., 2007; Tungsanga & Sriboonlue, 1993). As 
the most common cause of sudden deaths in young adults is the result of underlying 
previously unknown cardiopathology (Corrado, Basso, & Thiene, 2001: Maron et al., 
1996), much of the research has been focused on genetic cardiovascular 
pathophysiological risk factors for cardiac malfunction with respiratory risk factors rarely 
investigated. As SIDS, SUDEP, SUDC, and SUDS each appear to have overlapping 
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features with delineation arbitrarily made by age, it may be beneficial to model future 
SUDS research after more extensively studied sudden death syndromes. 
Eupneic and Stressed Breathing 
 Relaxed breathing (eupneic breathing) occurs during normally oxygenated 
environmental conditions (21% oxygen, O2; 79% nitrogen, N2). Respiration is defined by 
a number of accepted breathing characteristics that include minute ventilation (MV), 
which is the amount of air breathed per minute. Minute ventilation is the mathematical 
product of depth of breathing (tidal volume, TV) and frequency of breathing (f). The 
frequency of breathing includes many components of respiration that all contribute to the 
overall number of breath oscillations that can occur in one minute. One of these 
components is TV; the larger the TV, the longer it may take to inspire, and thus the lower 
the breath frequency could be (although the individual could simultaneously decrease 
their inspiratory time mitigating the effect of this increase in TV on f). Another 
interesting component of breath frequency is the end expiratory pause (EEP). The EEP is 
the time period that occurs following exhalation and before inhalation. EEP is an 
important breathing component in examining apnea, which is an extended EEP period 
that varies slightly in definition depending on species and is an indicator of disordered 
breathing and a reduced ability to compensate for rising blood CO2 levels (Feldman, 
Mitchell, & Nattie, 2003; Nattie, 1999). During normal eupneic breathing EEP periods 
consist of the minimal amount of time needed for the body to initiate and complete a 
reversal in breathing function from exhalation to inhalation. It is widely accepted that 
eupneic breathing is initiated and maintained by the pons and medullary structures of the 
hindbrain (Feldman et al., 2003).  
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 Stressed breathing occurs during challenging conditions of increased carbon 
dioxide (hypercapnia) or decreased levels of oxygen (hypoxia). Under these challenges 
compensatory respiratory patterns occur which increase overall MV via increases in TV, 
f, or both as EEP periods decrease. Such compensatory changes are crucial to reducing 
rising blood CO2 levels and increasing blood O2 levels. Typically as environmental CO2 
increases, and thus blood levels of CO2 increase, the phenotypic compensatory response 
is to increase breath frequency in an effort to expel the excess CO2. Shorter EEP periods 
facilitate this effort by reducing the amount of time of CO2 accumulation in the body 
before reintroducing O2 with inhalation. Hypoxia elicits a similar MV compensatory 
response, but the increases are typically the result of amplified TVs in an effort to absorb 
more available O2. Failure to respond appropriately to hypercapnic or hypoxic conditions 
by increasing MV while maintaining or decreasing EEPs will accordingly result in an 
increased body burden of CO2 with less available O2 for normal cellular functioning, with 
potentially fatal consequences (Moore, Zwillich, Battaglia, Cotton, & Weil, 1976).  
 Because it is well established that brainstem structures are responsible for eupneic 
breathing they have also served as the primary focus of investigation for failures of 
stressed breathing. Given the apparently consistent involvement of the cerebellum in 
multiple conditions involving sudden death it seems reasonable to expand the scope of 
investigation outside of the traditionally implicated brainstem structures, into other brain 
regions that have potential involvement in the regulation of stressed breathing. 
Specifically, it is possible that the cerebellum, a structure massively innervated by the 
pons and medullary brainstem regions, may play a modulatory role in cardiorespiratory 




 The cerebellum, also located in the hindbrain, has been well established as a 
structure importantly involved in motor control (Fine, Ionita, & Lohr, 2002; Manto et al., 
2012). It is generally regarded that the cerebellum is responsible for the smooth, fluid-
like coordination of voluntary movements as damage to this structure results in 
uncoordinated and ataxic behaviors proportional to the level of damage (Richter et al., 
2005). For many years, research on the cerebellum has remained confined within the 
realm of movement disorders. Recent research, however, has implicated this structure in 
multiple functions outside of motor control including cognitive abilities and 
cardiorespiratory modulation (Calton, Dickson, Harper, Goldowitz, & Mittleman, 2014; 
Dickson et al., 2013; Dickson et al., 2010; Fatemi et al., 2012).  
 The cerebellum appears to play little to no role in cardiorespiratory functioning 
during eupneic, relaxed breathing. Following complete cerebellectomy, eupneic patterns 
of respiration and blood pressure are unchanged (Janssen, Lutherer, & Barnes, 1981; Xu 
& Frazier, 1997; Xu, Owen, & Frazier, 1995; Xu, Taylor, Lee, & Frazier, 1993). The 
cerebellum, however, does appear to play an important role in respiratory responding 
under stressed conditions. Following complete cerebellectomy, respiration under hypoxic 
conditions is impaired as indicated by decreased minute ventilation, TV and f (Xu et al., 
1995).  
 One potential explanation for the involvement of the cerebellum in cardiac and 
respiratory responses in stressed conditions may involve one of the deep cerebellar nuclei 
(DCN), the fastigial nuclei (FN). The FN has been identified as a chemosensitive area of 
the brain, especially responsive to changes in blood levels of CO2 (Lutherer, Williams, & 
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Everse, 1989; Xu & Frazier, 2002). The FN appears to play a modulatory role in both 
cardiac and respiratory responses. In anesthetized cats, stimulation of the FN, but not the 
other cerebellar nuclei resulted in increases in blood pressure (Achari & Downman, 
1970). Further, low frequency electrical stimulation of the FN elicited an excitatory 
respiratory response in cats, while high frequency stimulation resulted in an inhibition of 
respiratory response with an increase in apneic episodes (Williams, Everse, & Lutherer, 
1989). 
 Involvement of the FN in cardiac and respiratory modulation appears specific to 
conditions of stress but not during eupneic breathing. Cell body lesions of this structure 
exerted no effect on normal respiratory patterns or arterial blood pressure (Takahashi et 
al., 1995). Under hypercapnic conditions, bilateral lesions of the FN resulted in an 
attenuated respiratory response to increasing levels of CO2 (Xu & Frazier, 2000; Xu et 
al., 1994) and when challenged with hypotension inducing drugs, heart rate and blood 
pressure recovery were additionally and significantly impaired (Chen & Lutherer, 1985; 
Chen, Williams, & Lutherer, 1994; Lutherer, Lutherer, Dormer, Janssen, & Barnes, 1983; 
Williams, Robinson, & Lutherer, 1986).  
 The FN is primarily innervated by the Purkinje cells of the cerebellar vermis 
(Kandel, 2000; Lu, Cao, Tokita, Heck, & Boughter, 2013; Zhang, Wang, & Zhu, 2016). 
Purkinje cells comprise the sole output of the cerebellum and global loss of these cells 
inhibit the ability of mice to recover appropriately from mild carbon dioxide exposure 
(Calton et al., 2014; Calton, Howard, Harper, Goldowitz, & Mittleman, 2016). Further, 
decreased cerebellar Purkinje cell number and density, especially in the vermis, is the 
most frequent finding in persons diagnosed with ASD—a population with a high 
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incidence of disordered breathing and a rate of mortality twice that of the general 
population (Fatemi et al., 2012; Mouridsen, Brønnum-Hansen, Rich, & Isager, 2008; 
Palmen, Engeland, Hof, & Schmitz, 2004; Pickett, Paculdo, Shavelle, & Strauss, 2006; 
Shavelle, Strauss, & Pickett, 2001).  
 Additionally, the cerebellum is richly innervated by serotonin (5-
hydroxytryptophan; 5-HT) projections and although the precise role is evidently 
complex, it has been suggested that 5-HT has a direct influence on deep cerebellar nuclei 
firing (Saitow, Hirono, & Suzuki, 2013) which would include the FN. Although the 
relationship between 5-HT and its effects in the cerebellum is incredibly complex both 
temporally and spatially, excessive cerebellar 5-HT has been shown to impair timing 
signals of the deep cerebellar nuclei (Saitow, Murano, & Suzuki, 2009) and blood 
hyperserotonemia has been reported in ASD patients although the central effects remain 
largely unknown (Whitaker-Azmitia, 2005). Further, in the Lurcher mouse, an animal 
model of cerebellar Purkinje cell loss (the most common finding in ASD), increased 
serotonin projections to the DCN have been observed which may suggest a rewiring of 
the 5-HT network in these cerebella (LeMarec, Hebert, Amdiss, Botez, & Reader, 1998; 
Strazielle, Lalonde, Riopel, Botez, & Reader, 1996). As serotonin is widely accepted as 
integral in respiratory modulation, and neuropathophysiogical changes in the number or 
distribution of 5-HT are suspected as influential in sudden unexplained death disordered 
breathing patterns (Feldman et al., 2003; Harper & Kinney, 2010; Richerson & 
Buchanan, 2011; Richter, Mazke, Wilken, & Ponimaskin, 2003), it may be necessary to 
investigate this complex relationship between cerebellar neuropathology including 
Purkinje cell loss or dysfunction, central serotonin, ASD symptomology, and breathing. 
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Although, to date, there have been no systematic investigations into unexplained deaths 
in the ASD population, mouse models with similar cerebellar neuropathology may help 
shed light on the possibility of vulnerability to unexplained death in this group. 
Animal Models of Developmental Cerebellar Neuropathology 
 Fmr1. Fragile mental retardation 1 (Fmr1) is a gene that encodes for fragile mental 
retardation protein (FMRP; Hagerman & Hagerman, 2002). Increased expression of the 
trinucleotide (CGG) segment of the Fmr1 gene results in silencing of the gene, which 
further results in a stop to FMRP production—key deficits in Fragile X syndrome (FXS). 
FXS is the most commonly inherited genetic cause of intellectual disability with up to 
33% of those afflicted meeting criteria for diagnosis of ASD (Rogers, Wehner, & 
Hagerman, 2001) and up to 25% being diagnosed with epilepsy (Berry-Kravis, 2002; 
Wisniewski, Segan, Miezejeski, Sersen, & Rudelli, 1991).The Fmr1 mouse also exhibits 
a silencing of the Fmr1 gene halting FMRP production and has been a widely used model 
for investigating the physiological and behavioral effects of FXS and autism (Bakker et 
al., 1994; Pietropaolo, Guilleminot, Martin, D’Amato, & Crusio, 2011).  
 Although there is little information about the likelihood of sudden death in the 
FXS population, investigations of persons diagnosed with both epilepsy and severe 
learning disorders revealed a risk for SUDEP three times the risk of patients with 
epilepsy alone (Nashef, Fish, Garner, Sander, & Shorvon, 1995) suggesting that those 
with both FXS and epilepsy also have an increased risk of sudden death. There is also 
mixed evidence to suggest that sleep apnea, especially obstructive sleep apnea, in the 
FXS population is elevated, although it has been proposed that facial abnormalities which 
accompany FXS may contribute to this risk with further reports suggesting the actual risk 
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is equal to the general population (Hagerman & Hagerman, 2002; Hersh & Saul, 2001; 
Juncos et al., 2011; Kidd et al., 2014; Tirosh & Borochowitz, 1992;). More recent 
evidence highlights this increased risk of apnea as being specific to persons diagnosed 
with FXS and ataxia syndrome—a movement disorder that is seen in a subgroup of FXS 
patients (Hamlin, Liu, Nguyen, Tassone, Zhang, & Hagerman, 2011). Interestingly, an 
increased incidence of apnea raises the distinct possibility of hypoxia-related Purkinje 
cell loss or damage, and there is evidence to support this relationship. Post-mortem 
investigations of persons with FXS who died suddenly have revealed that these deaths 
were likely the result of cardiorespiratory failure, and were associated with an increased 
incidence of cerebellar Purkinje cell loss and vermal atrophy (Greco et al., 2011; 
Sabaratnam, 2000). Whether the Fmr1 mouse experiences these apneic episodes remains 
to be investigated.  
 Lurcher. The Lurcher mouse has been used extensively for research on olivoponto 
cerebellar degeneration for over half a century. Litters of these mice are comprised of 
wildtype mice, mutant mice heterozygous for the spontaneous mutation of the glutamate 
receptor ionotropic delta 2 (GRID2) gene, and homozygous non-viable mice which die 
shortly after birth (Vogel, Caston, Yuzaki, Mariani, 2005). The cerebellum of the mutant 
mouse develops normally following birth but then exhibits the spontaneous GRID2 
mutation which results in apoptosis of the cerebellar Purkinje cells beginning around 
postnatal day (PND) 8 and culminating with nearly 100% loss by PND 28 (Caddy & 
Biscoe, 1979; Zuo et al., 1997). Thus this mouse is a model of developmental cerebellar 




 Investigation into the role of the cerebellum in modulating respiration events has 
revealed that that loss of cerebellar Purkinje cells in the Lurcher mutant is without effect 
on eupneic breathing, but causes deficits in initiating and maintaining appropriate 
respiratory response patterns to environmental challenges. The Lurcher mutant mouse, 
when exposed to minimally challenging levels of CO2 (2% and 4% CO2, 21% O2, N2 on 
balance), was slow to initiate compensatory increases in minute ventilation which 
persisted when re-introduced into normal room air conditions (0% CO2, 21% O2, 79% 
N2). This abnormal breathing pattern during recovery consisted of large sporadic gasps 
(large TVs) and extended apneic-like end-expiratory pause periods in the mutant mice, 
but not the wildtypes (Calton et al., 2014; Calton et al., 2016).  
 mdx. The mdx mouse, another unique animal model of developmental cerebellar 
Purkinje cell pathology, is a model of human Duchenne muscular dystrophy (DMD), a 
progressive disease of muscle deterioration which affects approximately 1 in 7,250 
human males (Romitti et al., 2015). The X-linked mutant mdx mouse exhibits a 
spontaneous point-mutation in the DMD gene resulting in a loss of expression of the 
protein dystrophin (Campbell, 1995; Sicinski et al., 1989). Loss of muscular dystrophin 
in humans results in progressive myopathy and eventual early death due to 
cardiorespiratory failure as a result of diaphragm deterioration (Gardner-Medwin & 
Sharpies, 1989). In the mdx mouse this myopathology is less pronounced than in the 
human condition with minimal reductions in life span, making this model more 
appropriate for studying the effects of the central rather than peripheral loss of dystrophin 
(Beastrom et al., 2011; Chamberlain, Metzger, Reyes, Townsend, & Faulkner, 2007). 
However, the precise role of dystrophin in the CNS remains controversial.  
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 Within the CNS, dystrophin is most concentrated in the cerebellum and co-
localized postsynaptically to cerebellar Purkinje cells (Lidov, Byers, Watkins & Kunkle, 
1990). Further, the lack of dystrophin in the cerebellum results in decreased Purkinje cell 
size, and reduced synaptic placticity as long-term depression of the Purkinje cells is 
inhibited (Anderson, Head, & Morely, 2004). This reduction in synaptic plasticity is 
thought to contribute to the cognitive deficits observed in boys with DMD, with nearly 
30% classified as intellectually impaired with a mean intelligence quotient one standard 
deviation below the corresponding normally developing population (Anderson, Head, 
Rae, & Morely, 2002; Cotton, Voudouris, & Greenwood, 2001). Disordered breathing 
within the DMD population, especially hypercapnic hypoventilation, is thought to be the 
sole result of the diaphragm musculature deficit and has been shown to increase in 
incidence along with increased muscular dystrophy (Ragette, Mellies, Schwake, Voit, & 
Teschler, 2002). Mild diaphragmatic inflammation has been reported as early as three 
months of age in mdx mice with accompanying minor decreases in minute ventilation 
compared to controls (Huang et al., 2011). It remains to be examined, however, if 
patterns of disordered breathing occur in mdx mice prior to measurable respiratory 
musculature degeneration.  
Purpose and Hypotheses 
 Experiment 1. The purpose of this study is to examine compensatory respiratory 
responses in multiple models of cerebellar neuropathology with differing levels of 
Purkinje cell loss or dysfunction to examine the specific significance of the Purkinje 
cells. Given that mutant Lurcher mice, with 100% global Purkinje cell loss exhibit 
significant respiratory response and recovery impairment during and following relatively 
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minimally challenging levels of O2 and CO2 exposure (Calton et al., 2014), it seemed 
reasonable that the next area of investigation should address the question of whether less 
severe forms of cerebellar Purkinje cell neuropathology would elicit similar effects, thus 
revealing the cerebellar Purkinje cells as a particularly key component of compensatory 
respiratory responses. Thus, it was hypothesized that the contribution of the cerebellar 
Purkinje cells to compensatory respiratory breathing patterns is so significant that the 
level of loss or dysfunction would be irrelevant—no differences between cerebellar 
mutant strains would emerge. It was further hypothesized that mutant Fmr1 and mdx 
mice would exhibit similar patterns of respiratory compensatory deficits as mutant 
Lurcher mice when environmentally challenged with decreased levels of O2,  increased 
levels of CO2, or both, when compared to their wildtype littermates. Specifically, within 
the three groups of cerebellar mutant mice (Fmr1, Lurcher, and mdx), it was expected 
that the mutants would respond to hypercapnic and hypoxic conditions less robustly than 
their wildtype littermates and this would be evidenced by smaller increases in TV or f or 
both during exposure. Further, the mutant genotypes within the three groups of mice 
would show significant impairment in the ability to recover from hypercapnic and 
hypoxic conditions in comparison to their wildtype littermates, which would be 
evidenced by a diminished ability to reestablish baseline TV and f values in comparison 
to the respiratory patterns of their wildtype counterparts. Finally, when breathing room 
air at baseline, no significant differences between mutant and wildtype mice were 
predicted.  
 Experiment 2. Following the finding of differences in breath frequency during 
recovery in experiment 1, the purpose of this study was to examine, in depth, two 
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components of breath frequency (TV and EEP) to pinpoint what may be driving the 
observed differences. Thus the first hypothesis was, taking into account weight in 
accordance with experiment 1, at baseline (room air) no differences between strain and 
genotype would occur in either TV or EEP—the animals would have equivalent depths of 
breathing and would all pause for an equal period of time between breaths. During 
hypercapnic recovery conditions it was further hypothesized that differences in TV would 
not occur—all animals would exhibit a progressive increase in TV in accordance with 
increasingly challenging levels of hypercapnic recovery. However, it was further 
hypothesized that during hypercapnic recovery conditions, differences observed in breath 
frequency from experiment 1 would be a direct result of EEP durations among genotypes. 
Specifically, mutant mice from each strain that exhibited reduced breath frequency in 
experiment 1 would present prolonged EEP times compared to their wildtype littermates. 
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Chapter 2: Experiment 1 Methodology 
Animals 
 The experimental animals for this project consisted of 36 randomly selected litter-
mate pairs (12 mutant and wildtype pairs for each of the three mouse strains: Fmr1, 
Lurcher, and mdx) that will were aged PND 60 at the onset of testing. A single pair was 
selected from each mating cage in order to avoid litter effects. Animals were bred and 
maintained in the Animal Care Facility located in the Department of Psychology at the 
University of Memphis. All animals were weaned at PND 25 +/- 3 days and sibling-
housed in groups of 3-5 in ventilated polystyrene cages. Animals were continuously 
maintained in a temperature controlled environment (21±1ºC) on a 12:12 light-dark cycle 
(lights on at 0700) and given access to food and water ad libitum. Original breeders 
(Fmr1, #004624, Fmr1 control #004828; Lurcher, #001046; mdx, #001801, mdx control 
#000476) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). It 
should be noted that each of these mutant mouse strains are on different genetic 
backgrounds (Fmr1 = FVB, Lurcher = C57BL/6J, and mdx = C57BL/10J). While genetic 
background has been shown to have a profound influence on behavioral phenotype 
(Doetschman, 2009; Spencer et al., 2011), we additionally hypothesized that the effect of 
genetic background is much smaller than the effects of cerebellar neuropathology on 
stressed breathing. Thus, mice made on different genetic backgrounds were specifically 
selected for these experiments. Although using multiple mutant mouse strains that share a 
common genetic background is clearly a more popular approach with its own advantages 
(Doetschman, 2009), the only way to determine if a phenotype is robust with respect to 
genetic background is to compare across multiple backgrounds. All experiments were 
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approved by the local Institutional Animal Care and Use Committee and were conducted 
in accordance with the National Institutes of Health Guidelines for the Care and Use of 
Laboratory Animals.  
Breeding 
 Fmr1. The breeding procedures for Fmr1 mice consisted of two phases. The first 
phase entailed the mating of male mice hemizygous for the Fmr1tm1Cgr targeted mutation 
(FVB.129P2-Fmr1tm1Cgr/J) with wildtype control females (FVB.129P2-Pde6b+ Tyrc-
ch/AntJ). This breeding strategy produced F2 litters composed of heterozygous females 
and wildtype males. Phase two consisted of mating F2 littermates to produce F3 litters of 
experimental mice that included hemizygous and wildtype males. Genotypes of all mice 
were confirmed at weaning with tail-snip polymerase chain reaction testing (PCR) 
through an outside source (Transnetyx, Cordova, TN, USA).  
 Lurcher. The inbreeding of Lurcher mice entailed the filial pairing of a non-
ataxic female wildtype (WT; B6CBACa Aw-J/A-Grid2+) with a mutant ataxic male 
heterozygous for the Lurcher spontaneous mutation (Lc/+; B6CBACa Aw-J/A-Grid2Lc). 
This breeding strategy produced litters composed of both heterozygous Lc/+ and WT 
mice. The Lc/+ mouse expresses this heterozygous Grid2 mutation resulting in nearly 
100% developmental cerebellar Purkinje cell loss by PND 28 and this mutation is 
phenotypically observable as early as PND 12 by ataxic gait, permitting the non-invasive 
differentiation of Lc/+ mice from their non-ataxic WT littermates (Zuo et al., 1997). 
 mdx. Breeding the mdx strain of mice also consisted of two phases. The first 
phase entailed mating original male mice hemizygous for the spontaneous X-
chromosome linked muscular dystrophy mutation (C57BL/10ScSn-Dmdmdx/ J) with 
	
20 
female controls (C57BL/10ScSnJ) to produce F2 litters of heterozygous females and 
wildtype males. Phase two consisted of mating F2 littermates to produce experimental F3 
litters that consist of homozygous and wildtype males. Genotypes of all mice were 
confirmed with tail-snip PCR at weaning through an outside source (Transnetyx, 
Cordova, TN, USA).  
Whole Body Plethysmography 
 Data were collected using a whole body plethysmography system (WBP; Emka 
Technologies, Falls Church, VA, USA) in accordance with previously established 
procedures (Calton et al., 2014). Briefly, animals were placed, unrestrained, into a 
cylindrical plexiglass chamber (volume ≈ 450ml) while the percentages of environmental 
O2, CO2, and N2 were manipulated by an in-house program using iOX2 software (Emka 
Technologies; Falls Church, VA, USA). A transducer is mounted to the WBP which 
converted pressure differentials in the chamber into electrical signals that were then 
transmitted to and interpreted by the software. An outflow ventilation pump is connected 
to the WBP to ensure a constant removal of exhaled CO2 at 0.8L/min in order to prevent 
fatal accumulation of this gas.  
Procedures 
 Mice were weighed prior to placement in the chamber and their weights (g) 
recorded for analysis. Additionally, the experimental room temperature (21°C +/-1°C) 
and humidity (25% +/-10%) were monitored daily to ensure stability throughout the 
experiment. Using Emka Technologies iOX2 software (Falls Church, NC; USA; 2013), 
three programs created in-house that have been previously published (Calton et al., 2014) 
were used to assess the subjects’ respiratory responses at baseline (normal room air; 21% 
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O2, 0% CO2 and 79% N2), and under conditions of hypercapnia and hypoxia. Mice were 
randomly assigned to either the hypercapnia or hypoxia condition on PND 60—an age at 
which cerebellar neuropathology has been observed in these strains of mice (Koekkoek et 
al., 2005; Snow, Anderson, & Fry, 2014; Zuo et al., 1997), and the second condition 
followed on PND 61. Each test day began with a 10-min habituation period, followed by 
a 4-min exposure to baseline (Room Air) period with respective exposure to conditions of 
hypercapnia or hypoxia to follow baseline.  
 Baseline. Following the 10-min habituation period, 4-min of baseline 
measurements began. The dependent variables (DVs) tidal volume (TV, mL) and breath 
frequency (f, breaths per minute; bpm) were recorded continuously under normal room 
air conditions.  
 Hypoxia. The entire hypoxia program was 52 min in duration and consisted of 
one beginning baseline (4-min) measurement as described above followed by four 
sequential reductions in O2 (19%, 17%, 15%, 13% O2, N2 on balance) with a return to 
normal room air between each successive challenge to minimize discomfort of the 
animals. Each of the four challenges consisted of a 2-min fill period (the amount of time 
necessary for the mass flow controllers to receive and execute the command to change 
the gas content of the WBP and for the WBP to subsequently reach the desired 
experimental gas percentages). The two minute fill period was followed by a 4-min 
exposure period. Following the final challenge (13% O2) and subsequent return to room 
air, the mice were removed from the chamber.  
 Hypercapnia. The hypercapnia program followed the same timeline as the 
hypoxia program with the exception that following the baseline period, O2 remained 
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constant at 21% and CO2 was successively increased (2%, 4%, 6%, 8% CO2, N2 balance). 
Again, following the final challenge (8% CO2) and the return to room air, the mice were 
removed from the chamber. 
Variables and Data Analyses 
 The DVs in all conditions were TV and f. Breath sampling parameters for tidal 
volume (the volume of air inhaled in one breath) and breath frequency were set at 
approximately twice the normal, eupneic levels for mice to account for increased levels 
of minute ventilation across the exposure programs (typical TV < 0.20 mL; typical f < 
500 bpm; Crosfill & Widdicombe, 1961; Lorenz, 2002). Breaths that met the sampling 
criteria were automatically averaged by the software in 10-s blocks across the duration of 
the 52-minute long experiment. Breaths that did not meet the sampling criteria were 
removed by the program automatically as movement artifacts.  
 Weights. Weights for the mice were recorded and analyzed with Strain (Fmr1, 
Lurcher, and mdx) and Genotype (mutant and wildtype) as the between subjects factors. 
Thus a 3 (Strain) x 2 (Genotype) analysis of variance (ANOVA) was performed to 
identify any weight differences. If significant differences were found, then weight was 
included in all subsequent analyses as a covariate. Using weight as a covariate in these 
instances eliminated the possibility of this factor having an effect on the results as it has 
previously been shown that body weight is tightly correlated with minute ventilation 
(Crossfill & Widdicombe, 1961). Correlations between weight and TV were further 
performed to identify the direction of the relationship between these variables. 
 Baseline. Because differences in body weight observed, the baselines collected 
prior to the hypercapnia and hypoxia conditions were compared using repeated measures 
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analyses of covariance (RMANCOVA), with separate analyses for each of the two DVs. 
Strain and genotype again served as the between subjects factors, Time Block (24, ten-
second time blocks) served as the within-subjects factor, and weight served as the 
covariate. Thus, each analysis was a 3 (Strain) x 2 (Genotype) x 24 (Time Block) mixed 
design.  
 Hypoxia and Hypercapnia. For each experimental program, separate 
RMANCOVA analyses for each DV were performed. Strain and Genotype served as the 
between-subjects factors. The within-subjects factors included four levels of Gas 
(Hypoxia 19%, 17%, 15%, 13% O2, or Hypercapnia 2%, 4%, 6%, 8% CO2). Each gas 
was subdivided into six, 2-minute Conditions (Fill, Exposure 1, Exposure 2, Refill, 
Recovery 1, Recovery 2). The 2-min conditions were each further subdivided into 12, 10-
s Time Blocks in order to accurately track changes in the variables. Finally, weight 
served as the covariate. Thus, each omnibus analysis was a 3 (Strain) x 2 (Genotype) x 4 
(Gas) x 6 (Condition) x 12 (Time Block) mixed design. Depending on the results of the 





Chapter 3: Experiment 2 Methodology 
Animals 
 Hypercapnic data files for each of 36 experimental animals were run in 
accordance with the procedures described below. The experimental groups consisted of 
six randomly selected littermate pairs from experiment 1 from each of the three strains. 
Procedures 
 Hypercapnic Data Files. The data files of each experimental mouse were 
reanalyzed with new parameters using Emka Technologies iOX2 software (Falls Church, 
NC; USA; 2013). The new paramaters eliminated the 10-second averaged time blocks 
and instead investigated each individual breath.  
 Weights. The weights of the randomly chosen mice was recorded for analysis as a 
covariate if necessary. 
 Baseline. The first 510 breaths from the new baseline file were used for analysis 
of the breath frequency components TV and EEP. In order to examine the individual 
components of breath frequency (TV and EEP) and to remove the confound of different 
breathing rates on these analyses an equal number of breaths (510) was chosen from all 
animals using previously described procedures (Calton et al., 2016). 
 Hypercapnic Recovery. The first 510 breaths from each of the four hypercapnic 
recovery conditions (2%, 4%, 6%, 8%) in the new data file were used for analysis. These 
breaths were extracted from the Recovery 1 and Recovery 2 periods described in 





Variables and Data Analyses 
 The dependent variables in all conditions were TV and EEP. Breath sampling 
parameters remained the same as experiment 1. Breaths that met the sampling criteria 
were added to the data file for later analysis. The program automatically removed breaths 
that did not meet the sampling criteria as movement artifacts.  
 Weights. Weights were again recorded for analysis with Strain (Fmr1, Lurcher, 
and mdx) and Genotype (mutant and wildtype) as the between subjects factors. Thus a 3 
(Strain) x 2 (Genotype) ANOVA was performed to identify any weight differences 
among the randomly selected pairs from the three different mutant mouse strains and 
determine the need for weight to be included in subsequent analyses as a covariate.  
 Baseline. Upon finding weight differences, the baseline collected prior to the 
hypercapnic conditions was examined using RMANCOVA with separate analyses for 
each of the two DVs. Strain and genotype served as the between subjects factors, while 
Breath (510) served as the within-subjects factor, and weights served as the covariate. 
Thus, each analysis was a 3 (Strain) x 2 (Genotype) x 510 (Breath) mixed design.  
 Hypercapnia Recovery. Two separate RMANCOVA analyses were performed 
for each DV (TV and EEP). Strain and Genotype again served as the between-subjects 
factors. The within-subjects factors included four levels of hypercapnia Recovery (from 
2%, 4%, 6%, & 8% CO2). Within each level of recovery the first 510 breaths were 
examined to identify moment-by-moment changes in breath frequency components. 
Weights again served as the covariate. Thus, each omnibus analysis was a 3 (Strain) x 2 
(Genotype) x 4 (Recovery) x 510 (Breaths) mixed design. Depending on the results of the 
Omnibus analyses, additional univariate analyses were performed.   
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Chapter 4: Experiment 1 Results 
Weights 
The results of a one-way ANOVA revealed there were significant differences in 
weights between Fmr1, Lurcher, and mdx mice (Strain, F (2, 66) = 60.788, p < .001). 
Post-hoc analyses revealed Lurcher mice (M = 20.271 g, SEM .402) weighed 
significantly less than both Fmr1 mice (M = 25.033 g, SEM .402) and mdx mice (M = 
26.183 g, SEM .402). Additionally, Pearson’s r revealed a significant positive correlation 
between the weights of the animals and their depth of breathing, r (70) = .430, p < .001 
(Figure 1). Thus, as body weight has been shown to be an important determinant of 
minute ventilation all subsequent analyses included weight as a covariate in order to 
remove the effect of weight as a factor in the results.  
Strain Weight and TV Correlation
Weight (g)





















mdxr2 = .0185, p < .001
	
Figure 1. Correlation between strain weight and tidal volume. Body weights and 
corresponding averaged baseline TVs for each animal of each strain are plotted along 





 Tidal Volume. During the baseline period, while breathing normal room air 
(21% O2, 0% CO2, 79% N2), RMANCOVA revealed Fmr1, Lurcher, and mdx mice 
differed in their depth of breathing (Figure 2; Strain, F (2, 65) = 5.04, p = .009) with 
Lurcher mice demonstrating a much smaller TV (M = .165, SEM = .007) than mdx mice 
(M = .199, SEM = .006). However, the depth of breathing in mutant mice and wildtype 
mice was equivalent, (Genotype, F (1, 65) = 2.92, p = n.s.).  
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Figure 2. Baseline tidal volume for both genotypes of each strain across time blocks. 
Mean tidal volume (± SEM) for each of the 24, 10-second time blocks amongst all strains 
and genotypes during normal room air (21% O2, 79%N2, 0% CO2). 
 
Breath Frequency. A second RMANCOVA during the baseline period under 
normal, room air conditions, revealed that the frequency of breathing among Fmr1, 
Lurcher, and mdx mice, and among the mutant mice and wildtype mice was non-
significantly different, (Figure 3; Strain, F (2, 65) = 2.19, p = n.s.; Genotype, F (1, 65) = 
.26, p = n.s.). Additionally, there was no interaction effect, (Strain x Genotype F (2, 65) = 
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Figure 3. Baseline breath frequency for both genotypes in each of the three strains across 
time blocks. Mean breath frequency (± SEM) for each of the 24, 10-second time blocks 
amongst all strains and genotypes during normal room air (21% O2, 79%N2, 0% CO2).  
 
Hypoxia 
Tidal Volume. The omnibus RMANCOVA revealed that exposure to decreased 
levels of atmospheric O2 had the expected results; all mice displayed gradual reductions 
in tidal volume as O2 decreased from 19% to 13% (Figure 4a; Gas F (3, 195) = 11.80, p = 
< .001). Additionally regardless of O2 condition or time, Lurcher mice as a group 
breathed more shallowly than the mdx and Fmr1 mice (Figure 4b; Strain F (2, 65) = 7.13, 



















































Figure 4. Main effects of gas and strain on tidal volume during hypoxia. Mean tidal 
volume (± SEM) for each of the hypoxic gas exposure periods amongst all strains and 
genotypes collapsed across conditions (a). Overall mean tidal volume (+/- SEM) for each 
mouse strain (b). * represents p < .05. 
 
As shown in Figure 5 (a, b, c), the RMANCOVA also identified genotypic differences by 
strain in TV that were related to test condition (Fill, Exposure 1, Exposure 2, Refill, 
Recovery 1, and Recovery 2; Strain x Genotype x Condition F (10, 325) = 3.11, p < 
.001). Regardless of gas exposure, the mdx mutants, showed larger reductions in TV than 
associated wildtype mice, that began to emerge during recovery 1 and intensified 
throughout recovery 2 (Figure 5c; Recovery 1, Genotype, F (1, 21) = 3.82, p = .06; 
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Figure 5. Recovery condition by strain by genotype effects on tidal volume during all 
hypoxic gas challenges. Mean tidal volume (± SEM) collapsed across all hypoxic gas 
exposures for Fmr1 mutant and wildtype mice (a), Lurcher mutant and wildtype mice 
(b), and mdx mutant and wildtype mice (c). * represents p < .05, † represents p < .06 
 
Breath Frequency. The omnibus RMANCOVA revealed two patterns of breath 
frequency reduction associated with changes in O2 concentration and test condition. First, 
all mice decreased their breath frequency as O2 concentration decreased (Figure 6a; Gas 
F (3, 195) = 53.37, p = < .001). Second, breath frequency declined significantly 
following exposure to reduced O2 concentrations, during chamber refill and recovery to 










































































Figure 6. Main effect of gas and condition on breath frequency during hypoxic 
challenges. Overall mean breath frequency (± SEM) for each of the hypoxic gas 
exposures (a), and for each of the hypoxic conditions (b). 
 
Further, when considered across the hypoxia program, breath frequency in the mutant and 
wildtype mice was equivalent (Data not shown; Genotype F (1, 65) = .05, p = n.s.). 
However, strain differences did emerge as Fmr1 mice exhibited lower overall breath 




































Figure 7. Main effect of group on breath frequency during hypoxic challenges. Overall 
mean breath frequency (± SEM) for each of the mouse strains across all hypoxic 
exposures and conditions. * represents p < .05 
 
Hypercapnia 
Tidal Volume. The omnibus RMANCOVA results indicated that when exposed 
to increasing levels of CO2, all mice exhibited typical response patterns, increasing their 
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Figure 8. Main effect of gas on tidal volume during hypercapnic gas exposures. Overall 
mean tidal volume (± SEM) for all strains and genotypes.  
 
 Further, when considered across conditions all mice showed typical curvilinear patterns 
of tidal volume response respective to condition (Figure 9).  
Means 







































Figure 9. Main effect of condition on tidal volume during hypercapnia. Overall mean 
tidal volume (± SEM) for each of the six conditions regardless of gas, strain, or genotype.  
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In all mice and genotypes, the depth of breathing increased from the fill period to the 
exposure periods and then gradually decreased as they transitioned from the refill period 
and return to room air, to the final [recovery 2] condition (Figure 10; Condition F (5, 
325) = 169.95, p = < .001).  
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Figure 10. Mean tidal volume (± SEM) for each strain and each genotype across all of the 
conditions. 
 
Breath Frequency. A final omnibus RMANCOVA revealed a typical 
compensatory pattern of breath frequency which decreased amongst all of the mice as 
CO2 concentration increased (Figure 11a; Gas F (3, 195) = 21.93, p = < .001). All mice 
also exhibited a typical curvilinear pattern of breath frequency response among the six 
conditions. In all mice breath frequency increased from the fill period to exposure 
periods, and then decreased following exposure through the final recovery period (Figure 
11b, Condition F (5, 325) = 33.94, p = < .001; Strain F (2, 65) = .32, p = n.s.).  
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Figure 11. Main effect of gas and condition on breath frequency during hypercapnia. 
Overall mean breath frequency (± SEM) for each of the four hypercapnic gasses (a) and 
for each of the six conditions (b).  
 
The omnibus RMANCOVA also revealed significant genotypic differences that 
occurred regardless of strain and in response to all changes in CO2 level. All mutant mice 
exhibited reduced breath frequencies across the hypercapnia program compared to 
wildtype mice (Genotype F (1, 65) = 4.45, p = .04). As shown in Figure 12 (a, b, c) 
dependent on the condition, the breath frequency between the genotypes differed 
significantly by strain (Strain x Genotype x Condition F (10, 330) = 2.21, p = .017). 
Specifically, during the fill period Lurcher and mdx mutant mice were slower to respond 
to increasing levels of CO2 compared to their wildtype littermates (Fill, Lurcher 
Genotype F (1, 21) = 6.39, p = .02, Figure 12b; mdx Genotype x time F (11, 242) = 1.79, 
p = .06, Figure 12c). During exposure 1 and exposure 2, mutant and wildtype mice in all 
groups had equivalent breath frequency. Lurcher mutants were the first to fail to maintain 
this increased level of breath frequency, beginning during refill to normal room air 
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(Refill, Lurcher Genotype F (1, 21) = 6.96, p = .02). Once the WBP achieved normal 
room air conditions, deficits in breath frequency occurred in all mutant mice. Thus, 
mutant Fmr1, Lurcher and mdx mice all had significantly reduced breath frequencies 
compared to their respective wildtype littermates during recovery 1 (Recovery 1, 
Genotype F (1, 65) = 5.45, p = .023) and this deficit diminished throughout recovery 2 
(Recovery 2, Genotype F (1, 65) = 3.89, p = .053).  





























































































































Figure 12. Effect of strain, genotype, and condition on breath frequency across 
hypercapnia. Mean breath frequency (± SEM) for each hypercapnic condition for Fmr1 
mice (a), Lurcher mice (b), and mdx mice (c). * represents p < .05, † represents p < .06.  
 
Simple main effects tests revealed that across the two recovery conditions, Lurcher 
mutants were the most impaired. Lurcher mutants had the largest decreases in breath 
frequency compared to Fmr1 and mdx mutants (Figure 13, Strain x Condition F (2, 33) = 
6.03, p = .01). 
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CO2 Breath Frequency during Recovery in Mutants
Condition 



























Figure 13. Mean breath frequency (± SEM) for mutants of each strain during recovery 1 




Chapter 5: Experiment 2 Results 
Weights 
The results of a 3 x 2 between subjects ANOVA revealed a significant main effect 
of strain, (Strain F (2, 30) = 37.06, p < .001). Specifically, Lurcher mice weighed 
significantly less (M = 20.40 g, SEM = .526) than Fmr1 (M = 25.00 g, SEM = .526) and 
mdx mice (M = 26.558 g, SEM = .526). However there was no difference between 
genotypes, F (1, 30) = .787, p = .382, and there was no interaction between group and 
genotype, F (2, 30) = 1.607, p = .217. Thus, as body weight has been shown to be an 
important determinant of minute ventilation all subsequent analyses included weight as a 
covariate to remove the effect of weight as a factor in the results. 
Baseline 
TV. Omnibus analysis revealed the depth of breathing (TV) across the 510 
breaths during normal room air was significantly higher in mdx mice (M = .207, SEM = 
.021) than Fmr1 (M = .184, SEM = .002) and Lurcher mice (M = .166, SEM = .020), 
(Figure 14; Strain F (2, 29) = 3.63, p = .039). However, this difference did not extend 
between the genotypes, (Genotype F (1, 29) = 1.04, p = n.s.). Further, there was no 
interaction between group and genotype, (Group x Genotype F (2, 29) = 0.11, p = n.s.).  
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Figure 14. Main effect of strain on tidal volume during baseline at normal room air (21% 
O2, 79% N2, 0% CO2) in experiment 2. Mean tidal volume (± SEM) for each mouse strain 
during baseline conditions across 510 breaths. * represents p < .05.  
 
EEP. A second RMANCOVA revealed the time spent between exhalation and 
inhalation (EEP) did not differ by strain, (Figure 15; Strain F (2, 29) = .11, p = n.s.), or 
genotype, (Genotype F (1, 29) = .07, p = n.s.), nor was there an interaction between 
group and genotype, (Group x Genotype F (2, 29) = .85, p = n.s.). 
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Figure 15. Main effect of strain on EEP during baseline at normal room air (21% O2, 
79% N2, 0% CO2) in experiment 2. Overall mean (± SEM) end expiratory pause (EEP) 
for each of the strains.  
 
Hypercapnic Recovery 
TV. Omnibus RMANCOVA revealed that during recovery all animals exhibited 
progressive increase in TV that corresponded to exposure to increasing concentrations of 
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Figure 16. Main effect of recovery condition on tidal volume in experiment 2. Overall 
mean tidal volume (± SEM) for each of the four hypercapnic recovery conditions. * 
represents p < .05.  
 
Further, mdx mice exhibited larger TVs overall (M = .210 ml, SEM = .016) than Fmr1 (M 
= .180 ml, SEM = .014) and Lurcher mice (M = .192 ml, SEM = .002), (Figure 17; Strain 
F (2, 29) = 4.04, p = .028). However, these differences did not extend to genotype, 
(Genotype F (1, 29) = .14, p = n.s.), nor was there an interaction between strain and 
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Figure 17. Main effect of strain on tidal volume in experiment 2. Overall mean tidal 
volume (± SEM) for each of the three mouse strains collapsed across all hypercapnic 
recovery conditions. * represents p < .05.  
 
EEP. The omnibus RMANCOVA revealed all animals had significantly increased 
their end expiratory pause durations between breaths corresponding to recovery from 
increasingly challenging levels of hypercapnia, (Figure 18; Recovery F (3, 90) = 2.79, p 
























Breath by Breath CO2 Recovery EEP by Recovery Condition
*
 
Figure 18. Main effect of recovery condition on EEP during recovery in experiment 2. 
Mean EEP (± SEM) time for all animals at each of the four hypercapnic recovery 
conditions. * represents p < .05.  
 
Additionally, regardless of strain, there was no significant difference in the amount of 
time the animals paused between breaths (EEP), (Strain F (2, 29) = .05, p = n.s.). 
Interestingly, regardless of strain, genotype appeared to have an effect on the pause time, 
with mutants pausing for longer periods of time between breaths (M = 23.680 ms, SEM = 
.558) than wildtypes (M = 17.121 ms, SEM = .558), although these differences only 
approached significance, (Figure 19; Genotype F (1, 29) = 3.96, p = .056). Analysis 
further revealed there was no significant interaction between the strains of mice and the 
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Figure 19. Effect of genotype on EEP during hypercapnic recovery in experiment 2. 
Overall mean EEP times (± SEM) for mutant and wildtype mice collapsed across all 




Chapter 6: Discussion 
Baseline 
 Differences between the animals’ weights emerged and as expected revealed a 
positive relationship in that body weight was coupled to TV. These results are reflective 
of the typical relationship between body mass and respiratory function (Crossfill & 
Widdicombe, 1961; Kleinman & Radford, 1964). Once weight was controlled for, 
animals of all strains breathed at equivalent rates (f) and took an equal amount of time to 
reverse their breath direction (EEP). These results further suggest that neither the 
cerebellar neuropathology nor any potential muscle-related weakness in the genotypes of 
each of these strains has an effect on normoxic ventilation in PND 60-61 mice.  
 Even after weight had been used as a covariate, Lurcher mice still exhibited much 
smaller TVs than both Fmr1 and mdx mice. However, as body weight is an indirect 
measure of assumed lung capacity, a more precise measure of lung capacity could be 
used as a covariate and would likely moderate these differences. Additionally, as the 
purpose of this investigation was to specifically identify the robustness of the effect of 
cerebellar neuropathological differences in breathing in multiple strains across multiple 
genetic backgrounds, this strain finding is ultimately unremarkable for the study at hand.  
Hypoxia 
 The response to repeated exposures to challenging hypoxic conditions in mice of 
all strains and genotypes resulted in a small decrease in MV (Figs. 4a, 6a). These results 
are not entirely surprising as the response to mild hypoxia (O2 levels > 10%) is far less 
robust than hypercapnia (Fong, 2010; Teppema & Dahan, 2010), and these same hypoxic 
response patterns were previously observed in Lurcher mice (Calton et al., 2014). The 
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overall decrease in MV across strains and conditions likely reflects the relatively brief 
time designated between successive hypoxic challenges, and suggests that mice were not 
given enough time to fully recover between these challenges.  
 Of unique interest were the response patterns of TV of mdx mutant mice across 
the hypoxic conditions (Figure 5c). While both genotypes of the Fmr1 and Lurcher mice 
maintained equivalent breathing patterns across all of the conditions (from fill to recovery 
2), the mutant mdx mice revealed a distinct inability to maintain their depth of breathing, 
with significant impairment by the time the animals reached recovery 2. That the mdx 
mutant mice TVs did not differ from the wildtype mice during normoxia or during the 
hypoxic fill and exposure conditions, and mdx mutant mice were able to attain and 
maintain TV levels during hypercapnia nearly double those observed in the hypoxic 
conditions (Figure 10), suggests this was not the result of an inability to achieve 
equivalent TVs.  
 It is possible that the significant reduction in TV following hypoxia may be 
indicative of fatigued diaphragm musculature in these animals as a result of dystrophin 
deficient myopathy (Figure 5c). While slow diaphragmatic degeneration begins around 
PND30 in these animals (Stedman et al., 1991), previous research has reported mixed 
evidence for a respiratory deficit prior to the first year of age in mdx mice. In one report, 
differences in MV between eight week old mdx mutant and wildtype animals were 
present during both baseline and hypoxic exposures (Burns, Edge, O’Malley, & 
O’Halloran, 2015). This possibility, however, appears unlikely as mdx mutants were fully 
capable of maintaining much larger TVs that were equivalent to wildtype mice when 
exposed to hypercapnic conditions (Figure 10c). Thus, a more parsimonious explanation 
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is that the impaired hypoxic recovery in mdx mice is related to peripheral chemoreceptor 
deficits attenuating the response patterns of the animals to hypoxia (Mosquiera, Baby, 
Lahiri, & Khurana, 2013). 
 It has been well established that respiratory response patterns to decreased 
environmental O2 are far less robust than the response patterns to increased CO2 and the 
control of these respiratory responses during development differs as well. Peripheral 
chemoreceptors are responsible for managing the hypoxic ventilatory response until the 
blood concentration of O2 drops significantly enough to achieve hypoxemia—a point at 
which central chemoreceptors take over (Lagercrantz & Rohdin, 2008). In mice, it has 
been shown that moderate hypoxemia occurs after 10 minutes of exposure to 7.9% O2 in 
5 month old normal mice (Gonzalez, Kumar, Mulligan, Davis, & Saupe, 2004). Thus it is 
probable the hypoxic conditions presented to the animals in the current study were not 
challenging enough to create conditions for central chemoreception to take precedence 
over peripheral receptors, likely because they were exposed to relatively mild hypoxic 
conditions (19, 17, 15, and 13% O2, N2 balance) for a short period of time (4 minutes 
each). This possibility is supported by the fact that the other two strains did not reveal 
genotypic differences in minute ventilation, which if they had, would suggest central 
involvement of the fastigial nuclei (Figure 5). It has further been reported that in 5-7 
month old mdx mice the diminished response to hypoxia is directly attributed to 
peripheral rather than central chemoreceptor deficits (Mosquiera et al., 2013). 
Additionally, that mdx O2 blood levels are lower than controls during normal room air 
conditions (Mosquiera et al., 2013) suggests it may be even more difficult to challenge 
	
48 
these animals centrally with decreased O2 levels, as chronically low arterial O2 levels 
weakens the response to hypoxic stimuli (Severinghaus, Bainton, & Carcelen, 1966). 
Hypercapnia 
 As anticipated, the most profound differences in MV emerged during the 
hypercapnia programs. First, as expected the TV and f response to hypercapnia in all 
animals followed a distinct curvilinear pattern, which accompanied the transitions across 
the six conditions (Figures 9, 11c). Animals increased their TV upon exposure to 
hypercapnia and reduced their TV during recovery—a characteristic response pattern 
(Moosavi et al., 2003; Sherwood, 1997). Further, the magnitude of change in TV 
increased as the level of hypercapnic challenge and recovery increased (2% TV < 4% TV 
< 6% TV < 8% TV; Figs 8, 16). Again, this was a typical response pattern as increased 
levels of hypercapnia elicit an increased response in MV in an effort to expel 
accumulating systemic CO2. However a different and abnormal pattern of hypercapnic 
responses occurred for breath frequency that was apparent across genotype, regardless of 
strain.  
 While the wildtype animals in all strains maintained nearly unchanged breath 
frequency across all CO2 exposures, mutant mice consistently had lower breath 
frequencies that were especially apparent during recovery (Figure 12). As mutants 
simultaneously maintained TV (Figure 10) at wildtype levels, and TV and f are 
components of minute ventilation, it is apparent that MV declined in all mutant mice. 
Breath by breath analysis further indicated that there were differences in EEPs between 
mutants and wildtype mice (Figure 19). Specifically, mutants had longer EEPs than 
wildtype animals which obviously contributed to the observed reductions in breath 
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frequency and MV in these animals. As the ability to increase MV is vital to effectively 
reducing blood levels of CO2, it should be apparent that all mutants regardless of strain, 
showed a compromised ability to reduce the body burden of CO2 and return to 
homeostasis (Edelman, Epstein, Lahiri, & Cherniack, 1973) and this vulnerability 
increases the level of concern for the likelihood of fatal CO2 accumulation in the mutant 
mice across the three strains.  
Relation to Previous Literature 
 Very little is known about disordered breathing patterns in the human FXS 
population and much of it is controversial. It has been reported that in 1,295 children with 
FXS or FXS carriers, persons with FXS reported an elevated incidence of sleep problems 
including excessive daytime sleepiness which is often used as an indicator of 
undiagnosed sleep apnea (Lavie, 1983; Kronk et al., 2010). Others who have directly 
investigated apnea in FXS patients have either reported that it occurs only in a subset of 
this population (FXS and ataxia syndrome) or that it only occurs in FXS patients with 
facial abnormalities and results in episodes of obstructive sleep apnea (Hagerman & 
Hagerman, 2002; Hamlin et al., 2011; Juncos et al., 2011; Kidd et al., 2014; Tirosh & 
Borochowitz, 1992). In the current study Fmr1 mice exhibited patterns of disordered 
breathing (including extended EEPs) following hypercapnia, which alludes to the 
possibility that the associated human population may be vulnerable to apneic episodes 
only when faced with a relatively mild environmental hypercapnic stressor. This 
possibility deserves further investigation.  
 Multiple clinical investigations in patients with FXS have reported on two 
cerebellar deficits; hypoplasia of the cerebellar vermis (Hoeft et al., 2010; Mostofsky et 
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al., 1998) and cerebellar Purkinje cell loss (Greco et al., 2011). Pre-clinical studies using 
magnetic resonance imaging and immunohistochemical analysis of the deep cerebellar 
nuclei of 30 PND Fmr1 mice revealed a significant reduction in the volume of the deep 
cerebellar nuclei, the main output of the cerebellum, compared to age- and sex-matched 
wildtype mice (Ellegood, Pacy, Hampson, Lerch, & Henkelman, 2010). Additionally, 
these authors noted a corresponding and significant reduction in the size of the fastigial 
nuclei of these mice.  
 The FN is a chemosensitive area of the cerebellum in humans and animals that 
modulates cardiorespiratory behavior when challenged and is especially responsive to 
hypercapnic conditions (Gozal et al., 1994; Lutherer et al., 1989; Xu & Frazier, 2002). 
Thus, it seems probable that a reduction in the volume of the FN would result in a 
reduction in chemosensitivity, limiting an organism’s ability to respond to or recover 
from increases in blood levels of CO2. Reductions in the size of the FN as well as all the 
DCN appear to be a direct consequence of Purkinje cell loss as both Fmr1 mice and 
Lurcher mutants have this combined neuropathology (Heckroth, 1994). Lurcher mice 
have previously been shown to have a reduced ability to respond to and recover from 
hypercapnic conditions, exhibiting signs of post-sigh apneic-like episodes with extended 
EEP durations (Calton et al., 2014; Calton et al. 2016). These results were replicated in 
the current study. As Fmr1 mutant mice also showed deficits in recovering from 
hypercapnia as effectively as their wildtype littermates, the current study highlights the 
importance of investigating challenged respiration, especially during hypercapnia, in 
persons with FXS. Specifically, based on the current results it would be expected that 
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FXS individuals may show increased incidences of apneic-like episodes (i.e. extended 
EEPs) after exposure to hypercapnia.  
 While extensive research has been performed on the dystrophin-deficient mdx 
mouse, there is scant literature on the progression of CNS modulated respiratory deficits 
that occur relative to well-described patterns of muscular [diaphragmatic] dystrophy in 
these animals. The few findings describing respiratory patterns in these animals have 
yielded mixed results. For example, a 20-minute, 10% O2 exposure period averaged over 
one-minute intervals found attenuated MV in eight-week old mdx mice and controls 
during both baseline and hypoxic exposure (Burns et al., 2016). While research on seven 
month old mdx and control mice revealed no baseline (room air) differences in tidal 
volume or breath frequency, but a diminished response during exposure to 7% CO2 in the 
mutant animals (Gosselin, Barkley, Spencer, McCormick & Farkas, 2003). Further, 
Gayraud et al. (2007) found no evidence for baseline or hypercapnic exposure differences 
in averaged breath frequency or tidal volume in five month old mdx mice. That the 
current findings further support evidence for no breathing differences in normoxia 
between mdx mice and wildtype mice by PND 60 despite mild diaphragm myopathy, it is 
quite possible these contradictory results may simply reflect the differing methodology 
used and additionally highlights the need for comparable testing strategies.  
 Although the precise role of dystrophin in the CNS remains largely unknown, it is 
widely believed that the learning disabilities associated with conditions such as 
Duchenne’s muscular dystrophy are directly related to the central loss of dystrophin 
(Cyrulnik & Hinton, 2008; Kim, Wu, & Black, 1995; Uchino et al., 1994). Dystrophin 
has been found in the highest concentrations in the cerebellum, co-localized in cerebellar 
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Purkinje cells, which suggests a critical role of dystrophin in Purkinje cell function. In 
fact, evidence from dystrophin-deficient mdx mice has revealed evidence supporting a 
reduction of postsynaptic γ-aminobutyric acid (GABAA) receptor clusters corresponding 
with a reduction in inhibitory input in Purkinje cells in the cerebella of these mice 
(Anderson et al., 2003). As reductions in Purkinje cell excitability would affect 
downstream DCN function including the FN, it is probable the observed reduced CO2 
sensitivity in mdx mice in the current study is an outcome related to dystrophin-mediated 
synaptic connectivity alterations.  
Implications and Future Research 
 As disordered breathing patterns would put a person, regardless of age, at 
increased risk for ventilatory failure, and potentially subsequent sudden unexpected 
death, it appears necessary to extend investigation into populations that exhibit both 
cerebellar neuropathology and disordered breathing. Autism spectrum disorders are one 
such condition with an increased incidence of breathing disorders and frequently reported 
neuropathological changes to the cerebellum including Purkinje cell loss and DCN 
volume variations (Fatemi et al., 2012; Kemper & Bauman, 1998). Although several 
reports have described an increased risk of mortality in persons with ASD, especially in 
persons with ASD and epilepsy (Hirvikoski et al., 2016; Mouridson et al., 2008), the 
likelihood of sudden unexpected and / or unexplained death remains to be investigated in 
this population. Further, as ASD is frequently diagnosed in persons with other diagnosed 
neuropathological disorders, it would be advisable to expand the examination of sudden 
unexpected or unexplained death to multiple clinical conditions.  
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 There are several neurodevelopmental disorders with high levels of comorbidity 
with ASD, cerebellar neuropathology, and disordered breathing including Fragile-X, 
Joubert, Prader-Willi, and Rett syndromes. These syndromes have documented cerebellar 
vermal agenesis or dysgenesis (Joubert—Joubert, Eisenring, Preston, & Andermann, 
1969), cerebellar hypoplasia (Prader-Willi–Titomanlio et al., 2006; Rett—Schaefer et al., 
1996) and cerebellar atrophy and Purkinje cell loss (FXS—Brunberg et al., 2002; Rett—
Murakami, Courchesne, Haas, Press, & Yeung-Courchesne, 1992). It has been commonly 
reported that persons with these syndromes show an increased incidence of apnea during 
the day as well as a heightened incidence of sleep apnea (Joubert—Wolfe, Lakadamyali, 
& Mutlu, 2010; Prader-Willi—Festen et al., 2011; Holm, Cassidy, Whitman, & Butler, 
1993; Rett—Weese-Mayer et al., 2006). It should also be noted that, in the syndromes 
that have been studied most extensively, there is an elevated comorbidity of seizures and 
epilepsy (FXS—Berry-Kravis, 2002; Prader-Willi—Vendrame et al., 2010; Zafeiriou, 
Ververi, & Vargiami, 2007; Rett—Dolce, Ben-Zeev, Naidu, & Kossoff, 2013) as well as 
evidence of increased prevalence of sudden death (FXS— Fryns, Moerman, Gilis, 
d'Espallier, & Berghe, 1988; Prader-Willi—Einfeld et al., 2006; Rett—Fyfe, Leonard, 
Dye, & Leonard, 1999). Thus, special emphasis should be placed on methodically 
examining the relationships among conditions presenting with ASD symptomology, 
cerebellar neuropathology (especially Purkinje cell loss or dysfunction and vermal 
abnormalities), disordered breathing, and sudden death.  
 Epilepsy is another challenging neurological condition for researchers that 
frequently presents with ASD symptomology and disordered breathing patterns as well as 
increased vulnerability to sudden unexpected death. Cerebellar neuropathology, 
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especially Purkinje cell loss, is common in persons with epilepsy and victims of SUDEP 
although the precise cause is controversial (Botez et al., 1988; Dam, 1987; Thom et al., 
2015). While some researchers suggest the cause is related to repeated exposure to 
hypoxia following multiple grand-mal seizures (Dam et al., 2007; Spielmeyer, 1930), 
others suggest the cause may be related to AED use (Brostoff et al., 2008; Crooks, 
Mitchell, & Thom, 2000; McLain et al., 1980; Ney, Lantos, Barr, & Schaul, 1994). 
Regardless of the cause of the Purkinje cell loss in this population, however, the current 
study indicates that loss or even dysfunction of these cells results in disordered breathing 
patterns that may put someone at risk for sudden death. Thus, it is likely the cerebellar 
Purkinje cell loss observed in SUDEP victims may not simply be a benign effect, but 
rather may have contributed to the fatal event. Further, given substantial evidence of the 
relationship between the cerebellar Purkinje cells and the FN—a modulator of 
cardiorespiratory response patterns (Lutherer et al., 1989; Rector, Richard, & Harper, 
2006;  Xu & Frazier, 2002), and that treatments of epilepsy often include AEDs which 
induce or exacerbate cerebellar damage including atrophy and Purkinje cell loss (Brostoff 
et al., 2008; Crooks et al., 2000; Eldridge et al., 1983; Mclain et al., 1980), it can be 
concluded these treatments may be placing patients at further risk for sudden unexpected 
death and alternative approaches should be prioritized. 
 Dravet syndrome (DS) is an extreme form of myoclonic epilepsy that typically 
presents in infancy or early childhood and is associated with a significant rate of 
premature mortality and SUDEP (Genton, Velizarova, & Dravet, 2011; Kalume, 2013). 
Intellectual disabilities and ASD are present in up to 98% of children and adults with 
Dravet syndrome (Berkvens et al., 2015; Li et al., 2011). Although DS is generally drug 
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resistant, clinical symptom treatment often includes the use of multiple AEDs. Given the 
low response of DS to AEDs, the families of DS patients often resort to popular social 
treatments including adopting a ketogenic diet or using cannabinoid oil although 
scientific evidence of their efficacy is absent (Scichilone, Yarraguntla, Charalambides, 
Harney, & Butler, 2016). Clinical investigation has described recurrent cerebellar atrophy 
and Purkinje cell loss in a mixed population that included both living and deceased 
persons with epilepsy (including SUDEP victims) with or without DS (Catarino et al., 
2011). Further, preclinical evidence of impaired cerebellar Purkinje cell firing is thought 
to cause ataxia associated with Dravet syndrome (Catterall, Kalume, & Oakley, 2010). 
Although direct evidence of disordered breathing in this subset of epilepsy patients 
remains to be described, it is commonly inferred that this group is particularly at risk for 
cardiorespiratory deficits—a key factor involved in SUDEP susceptibility (Kalume, 
2013; Nashef, Hindocha, & Makoff, 2007). Considering the documented frequency of 
cerebellar neuropathology (specifically Purkinje cell loss) and the increased risk for 
SUDEP in the DS population, assumptions of disordered breathing patterns appear 
justified and should be verified in future investigations. Further it seems reasonable to 
conclude the pathologies reported in DS patients may be cyclical—repeated severe 
seizures result in hypoxic cerebellar Purkinje cell death, which would perpetuate 
intellectual disability or ASD symptoms and further increase the risk for disordered 
breathing. Disordered breathing patterns would, in sequence, increase the risk for hypoxic 
cerebellar neuronal death, and the cycle would repeat until the ultimate sudden demise of 
a challenged patient by cardiorespiratory failure. Thus, research in DS may be 
complicated and these relationships deserve further investigation. 
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 Serotonin is another interesting component of breathing worth consideration. 
Serotonin, particularly important during development, exerts effects on cardiorespiratory 
behavior in a manner that is not entirely understood and neuropathological changes in the 
number or distribution of 5-HT containing neurons can directly influence this activity 
(Richter et al., 2003). The brainstems of SIDS victims consistently reveal 5-HT 
abnormalities including decreased 5-HT receptor binding in the medulla (Panigraphy et 
al., 2000). The Lurcher mouse, along with global cerebellar Purkinje cell loss, exhibits an 
extensive increase in 5-HT projections to the deep cerebellar nuclei, including the 
fastigial nuclei (LeMarec et al., 1998; Strazielle et al., 1996). As cerebellar Purkinje cell 
loss is the most commonly reported deficit in patients with ASD (Fatemi et al., 2012) and 
research reports ASD patients have pathological changes in platelet 5-HT which includes 
abnormally low levels during early development and abnormally high levels in 
adolescence and especially adulthood (Chugani, Muzik, Chakraborty, Mangner, & 
Chugani, 1998), investigation on central neuropathological 5-HT changes in this 
population should be pursued. 
  Medicinal treatment options for some of the symptoms of ASDs, FXS, and 
epilepsy includes the use of selective serotonin reuptake inhibitors (SSRIs), especially in 
early childhood (Albano, Cupello, Mainardi, Scarrone, & Favale, 2006; Aman, Lam, & 
Van Bourgondien, 2005; Berry-Kravis & Potanos, 2004) suggesting hypofunction of 
serotonin in these disorders. Interestingly, the use of SSRIs in clinical research has 
revealed these medications may be an effective method for modulating disordered 
breathing patterns including apnea (Kraiczi, Hedner, Dahlof, Ejnell, & Carlson, 1999). 
Further, a decreased hypercapnic ventilatory response has been reported in rats with 
	
57 
decreased cerebral 5-HT and SSRIs have been shown to augment this response (Hodges, 
Echert, Puissant, & Mouradian, 2013). Although how 5-HT dysfunction or dysregulation 
contributes to disordered breathing patterns remains unknown, it is evident this 
neurochemical system is significantly complex and future investigations should include 
examination of central serotonergic neuropathology in populations with disordered 
breathing. Further, given that persons with FXS, ASD, and Duchenne’s exhibit apparent 
pathological serotonergic changes, 5-HT exerts a direct effect on cardiorespiratory 
behavior, and the current results suggest disordered breathing occurs during recovery 
from mild hypercapnic challenges in these groups, these complex relationships with the 
potential risk for sudden death should be considered. 
 It is important to address that although each of the aforementioned disorders may 
have additional neurological or physiological deficits, in the literature there is a clear 
pattern of relationship within these disorders with cerebellar neuropathology, autism 
spectrum disorder symptomology, disordered breathing, and sudden unexpected death 
incidence greater than the general population. As there are multiple categories of sudden 
death typically demarcated by developmental stage, special attention should be directed 
towards those who exhibit these apparently clustered risk factors regardless of age. 
Further, the consistent reporting of this tetra-factorial risk provides additional credence to 
the necessity of developing unified nationwide post-mortem sudden death protocols to 
further the knowledge base on these syndromes.  
Conclusion 
 The purpose of this study was to investigate three components (TV, f, and EEP) of 
direct and indirect influence on minute ventilation under conditions of normoxia, 
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hypoxia, and hypercapnia in three mutant mouse strains that displayed a variety of 
developmental cerebellar neuropathologies in comparison to their wildtype littermates. 
The goal of these studies was to determine if these heterogeneous, cerebellar 
neuropathological differences contribute to stressed breathing, and thus contribute to an 
increased risk for sudden death. Throughout normoxia and hypoxic conditions mutant 
and wildtype mice maintained similar levels of minute ventilation and exhibited similar 
respiratory response patterns. However, in response to hypercapnic challenges, mutant 
mice of all strains revealed an impaired ability to appropriately recover by failing to 
maintain their breath frequency. This failure was a result of an increase in the pause time 
between breaths—a sign of an increased incidence of apnea. As apnea reduces an 
individual’s ability to appropriately re-establish homeostatic blood O2 and CO2 levels, 
these results suggest not only substantial cerebellar Purkinje cell loss, but even mild 
dysfunction or dysregulation of the cerebellar Purkinje cells, may contribute to a failed 
respiratory response. Further, as cardiorespiratory failure is believed to be the cause of 
death in multiple sudden unexplained death events, it is possible the neuropathological 
findings reported in the cerebella of these victims did not occur as a result of the death, 
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